Bharat Immunological & Biologicals Corporation Share Price
₹25.27 +1.17 (4.85%)
05 Jan, 2025 13:16
Start SIP in BIBCL
Start SIPPerformance
- Low
- ₹0
- High
- ₹0
- 52 Week Low
- ₹0
- 52 Week High
- ₹0
- Open Price₹0
- Previous Close₹0
- Volume0
Investment Returns
- Over 1 Month -3.44%
- Over 3 Month -7.91%
- Over 6 Month -13.07%
- Over 1 Year -25.04%
Smart Investing Starts Here Start SIP with Bharat Immunological & Biologicals Corporation for Steady Growth!
Bharat Immunological & Biologicals Corporation Fundamentals Fundamentals refer to the financial data that companies report on a quarterly or annual basis.
Bharat Immunological & Biologicals Corporation Financials
Bharat Immunological & Biologicals Corporation Technicals
EMA & SMA
Current Price
₹25.27
+
1.17
(4.85%)
- Bullish Moving Average 11
- Bearish Moving Average 5
- 20 Day
- ₹24.39
- 50 Day
- ₹24.97
- 100 Day
- ₹26.12
- 200 Day
- ₹27.31
Resistance and Support
24.95
- R3 27.25
- R2 26.38
- R1 25.82
- S1 24.39
- S2 23.52
- S3 22.96
Bharat Immunological & Biologicals Corporation Corporate Actions - Bonus, Splits, Dividends
Date | Purpose | Remarks |
---|---|---|
2024-08-16 | General Purpose. | |
2024-03-08 | Others | General Purpose |
2023-10-31 | Quarterly Results | |
2023-04-24 | Audited Results | |
2023-02-09 | Quarterly Results |
Bharat Immunological & Biologicals Corporation F&O
About Bharat Immunological & Biologicals Corporation
- NSE Symbol
- BIBCL
- BSE Symbol
- 524663
- ISIN
- INE994B01014
Similar Stocks to Bharat Immunological & Biologicals Corporation
Bharat Immunological & Biologicals Corporation FAQs
Bharat Immunological & Biologicals Corporation share price is ₹25 As on 05 January, 2025 | 13:02
The Market Cap of Bharat Immunological & Biologicals Corporation is ₹109.1 Cr As on 05 January, 2025 | 13:02
The P/E ratio of Bharat Immunological & Biologicals Corporation is -5.9 As on 05 January, 2025 | 13:02
The PB ratio of Bharat Immunological & Biologicals Corporation is 1.2 As on 05 January, 2025 | 13:02
Disclaimer: Investment in securities market are subject to market risks, read all the related documents carefully before investing. For detailed disclaimer please Click here.